Weekly Pharmacology Exam - April 17, 2026 (Section A: MCQs)

60 clinical MCQs in Weekly Exam: Pharmacology. A patient receives a drug dose of 500 mg daily. To express this dose normalized to body we

Questions, Answers & Explanations

  1. Q1. A patient receives a drug dose of 500 mg daily. To express this dose normalized to body weight for a 70 kg patient, what unit would be most appropriate?

    Answer: mg/kg

    Explanation: Normalizing a dose to body weight is standardly expressed as mg of drug per kg of body weight (mg/kg).

  2. Q2. The LD50 of a new compound is determined to be 200 mg/kg, while its ED50 is 20 mg/kg. What is the Therapeutic Index (TI) of this drug?

    Answer: 180

    Explanation: Therapeutic Index (TI) is calculated as LD50/ED50. 200 / 20 = 10.

  3. Q3. Which of the following best describes the 'threshold dose' in a dose-response relationship?

    Answer: The dose below which no effect is observed

    Explanation: The threshold dose is the lowest dose at which a particular measurable effect or response first occurs.

  4. Q4. A drug has an LD01 of 100 mg/kg and an ED99 of 80 mg/kg. What is the Margin of Safety (MOS)?

    Answer: 1.25

    Explanation: Margin of Safety (MOS) is often calculated as LD01/ED99. 100 / 80 = 1.25.

  5. Q5. According to toxicity scales, a substance with an LD50 of 400 mg/kg would be classified as:

    Answer: Moderately toxic

    Explanation: In standard Hodge and Sterner scales, substances with an LD50 between 50-500 mg/kg are categorized as moderately toxic.

  6. Q6. In dose-response curves, 'potency' refers to:

    Answer: The concentration of drug required to produce a specific effect of given intensity

    Explanation: Potency is a measure of the amount of drug (dose/concentration) required to produce an effect of a given magnitude (usually EC50).

  7. Q7. NOAEL stands for:

    Answer: No Observed Adverse Effect Level

    Explanation: NOAEL is the No Observed Adverse Effect Level, used in toxicology to determine the highest dose that does not produce a significant increase in adverse effects.

  8. Q8. A drug with TD50 of 150 mg and ED50 of 50 mg would have what Therapeutic Index (TI)?

    Answer: 100

    Explanation: TI = TD50 / ED50 = 150 / 50 = 3.

  9. Q9. When comparing two drugs on a dose-response curve, if Drug A's curve is shifted to the left of Drug B's curve, this indicates:

    Answer: Drug A is more potent than Drug B

    Explanation: A leftward shift on the x-axis (dose) indicates that a lower dose is required to achieve the same effect, meaning the drug is more potent.

  10. Q10. Tyramine produces its sympathomimetic effects primarily by which mechanism?

    Answer: Displacing stored norepinephrine from nerve terminals

    Explanation: Tyramine is an indirect-acting sympathomimetic that enters nerve endings via the reuptake transporter and displaces stored norepinephrine.

  11. Q11. Why is tyramine normally inactive when consumed orally in food?

    Answer: It is rapidly metabolized by MAO-A in the gut and liver

    Explanation: Tyramine is heavily metabolized by Monoamine Oxidase (MAO) Type A in the intestinal wall and liver before reaching systemic circulation.

  12. Q12. A patient taking a nonselective MAO inhibitor consumes aged cheese containing high tyramine levels. What is the most likely consequence?

    Answer: Hypertensive crisis

    Explanation: MAO inhibitors prevent the breakdown of tyramine, leading to massive release of norepinephrine, causing a dangerous rise in blood pressure.

  13. Q13. Pharmacodynamics includes the study of:

    Answer: Biochemical and physiological effects of drugs and their mechanisms of action

    Explanation: Pharmacodynamics explains what the drug does to the body (mechanisms and effects), while pharmacokinetics explains what the body does to the drug.

  14. Q14. Which of the following physiological changes in the elderly may lead to the need to reduce the dose of a prescribed medication?

    Answer: Decreased liver blood flow and muscle mass

    Explanation: Reduced liver blood flow decreases metabolism, and reduced muscle mass often correlates with reduced renal clearance, necessitating lower doses to avoid toxicity.

  15. Q15. What does the term 'affinity' mean?

    Answer: The strength of binding between a drug and its receptor

    Explanation: Affinity refers to the tendency of a drug to bind to a specific receptor.

  16. Q16. A pharmacological antagonist is a drug that:

    Answer: Binds to a receptor but produces no response, preventing agonist binding

    Explanation: Antagonists have affinity for the receptor but zero intrinsic activity (efficacy), thereby blocking agonists.

  17. Q17. Irreversible inhibition of a receptor or enzyme is typically due to:

    Answer: Covalent bonding

    Explanation: Covalent bonds are strong and stable, making the inhibition irreversible as the drug cannot easily dissociate.

  18. Q18. Drug receptors are found on:

    Answer: Extracellularly, on the cell surface, and intracellularly

    Explanation: Receptors can be located on the plasma membrane, in the cytoplasm, or in the nucleus (e.g., steroid receptors).

  19. Q19. Which of the following is the neurotransmitter agent normally released in the sinoatrial node (SAN) of the heart in response to an increase in blood pressure via the baroreceptor reflex?

    Answer: Acetylcholine

    Explanation: The baroreceptor reflex responds to high BP by increasing parasympathetic tone, releasing Acetylcholine to slow the heart rate.

  20. Q20. Which of the following drugs facilitates catecholamine transmitter release from adrenergic nerve endings?

    Answer: Amphetamine

    Explanation: Amphetamines act similarly to tyramine, promoting the release of stored norepinephrine into the synapse.

  21. Q21. Full activation of the sympathetic nervous system (fight-or-flight) occurs during maximal exercise. Which of the following effects is most likely?

    Answer: Mydriasis

    Explanation: Sympathetic activation causes pupillary dilation (mydriasis) to allow more light into the eye.

  22. Q22. Probable signs of atropine overdose in toddlers include which one of the following?

    Answer: Hyperthermia and flushed skin

    Explanation: Atropine poisoning is described as 'Hot as a hare, Red as a beet, Dry as a bone, Blind as a bat, Mad as a hatter'—indicating hyperthermia and vasodilation.

  23. Q23. Which is the treatment of choice in a child with signs of anaphylaxis after being stung by three bees?

    Answer: Epinephrine

    Explanation: Epinephrine is the first-line treatment for anaphylaxis due to its ability to cause vasoconstriction and bronchodilation.

  24. Q24. Epinephrine causes a decrease in:

    Answer: Cutaneous blood flow

    Explanation: Epinephrine causes alpha-1 mediated vasoconstriction in the skin and viscera, decreasing cutaneous blood flow.

  25. Q25. The study of the relationship between drug concentration at the site of action and the resulting effect is called:

    Answer: Pharmacodynamics

    Explanation: Pharmacodynamics focuses on the interaction between drugs and their targets and the resulting physiological effects.

  26. Q26. A partial agonist is a drug that:

    Answer: Binds to a receptor but cannot produce a maximal response even at high doses

    Explanation: Partial agonists have lower intrinsic activity than full agonists and cannot achieve Emax regardless of concentration.

  27. Q27. The 'therapeutic window' refers to:

    Answer: The range of doses between the minimum effective concentration and the minimum toxic concentration

    Explanation: The therapeutic window describes the safe range of drug levels that provide clinical benefit without excessive toxicity.

  28. Q28. Which of the following receptors is a G-protein coupled receptor?

    Answer: Muscarinic receptor

    Explanation: Muscarinic receptors (M1-M5) are GPCRs, whereas nicotinic and GABA-A receptors are ion channels.

  29. Q29. An example of a physiological antagonist is:

    Answer: Epinephrine antagonizing histamine-induced bronchoconstriction

    Explanation: Physiological antagonism involves two agonists acting on different receptors to produce opposite physiological effects.

  30. Q30. The ED50 is defined as:

    Answer: The dose that is effective in 50% of the population

    Explanation: The Effective Dose 50 (ED50) in quantal dose-response curves is the dose at which 50% of individuals exhibit the specified effect.

  31. Q31. Competitive antagonism can be overcome by:

    Answer: Increasing the concentration of the agonist

    Explanation: Because competitive antagonists compete for the same site, increasing agonist concentration can displace the antagonist.

  32. Q32. Which term describes the maximal effect (Emax) a drug can achieve?

    Answer: Efficacy

    Explanation: Efficacy refers to the maximum intensity of response a drug can produce.

  33. Q33. The addition of a non-competitive antagonist to an agonist will:

    Answer: Decrease the maximum response (Emax) of the agonist

    Explanation: Non-competitive antagonists bind irreversibly or to an allosteric site, reducing the total available functional receptors and thus decreasing Emax.

  34. Q34. If a drug has a high Therapeutic Index, it implies:

    Answer: There is a large margin between the effective and toxic doses

    Explanation: A high TI means the toxic dose is much higher than the therapeutic dose, making the drug relatively safe.

  35. Q35. Spare receptors exist when:

    Answer: The maximum response is achieved at a concentration where not all receptors are occupied

    Explanation: Spare receptors allow for maximal physiological response at low levels of receptor occupancy, increasing sensitivity to agonists.

  36. Q36. Tachyphylaxis is defined as:

    Answer: A rapid decrease in response to a drug after repeated administration

    Explanation: Tachyphylaxis is an acute, rapid decrease in the response to a drug after its administration.

  37. Q37. A drug that binds to the same site as the endogenous ligand but produces the opposite pharmacological effect is a(n):

    Answer: Inverse agonist

    Explanation: Inverse agonists reduce the constitutive (baseline) activity of a receptor, producing an effect opposite to the agonist.

  38. Q38. Which of the following is an example of a Type II (Ionotropic) receptor?

    Answer: Nicotinic Acetylcholine receptor

    Explanation: Nicotinic receptors are ligand-gated ion channels (ionotropic receptors).

  39. Q39. The term 'EC50' refers to:

    Answer: The concentration of a drug that produces 50% of the maximal effect

    Explanation: EC50 is the 'half-maximal effective concentration' used to measure potency in a graded dose-response curve.

  40. Q40. In the presence of a non-competitive antagonist, the agonist's log dose-response curve will show:

    Answer: A decrease in the slope and a reduction in the maximum height (Emax)

    Explanation: Non-competitive antagonists reduce the maximum efficacy (downward shift) and cannot be overcome by more agonist.

  41. Q41. Quantal dose-response curves are used to determine:

    Answer: The percentage of a population that shows an all-or-none response

    Explanation: Quantal responses are 'all-or-none' (e.g., sleep/no sleep, dead/alive) and are used to see population distributions.

  42. Q42. Which of the following best defines an 'antidote'?

    Answer: A substance that neutralizes or counteracts the effects of a poison

    Explanation: Antidotes counteract toxins through various chemical, pharmacological, or physiological mechanisms.

  43. Q43. A substance with an LD50 of 5 mg/kg is categorized as:

    Answer: Extremely toxic

    Explanation: LD50 values less than 5-10 mg/kg are typically classified as extremely toxic.

  44. Q44. Which of the following describes 'chemical antagonism'?

    Answer: A drug reacting chemically with another drug to form an inactive complex

    Explanation: Chemical antagonism (e.g., chelating agents) occurs when the antagonist reacts directly with the agonist/toxin to neutralize it.

  45. Q45. Down-regulation of receptors usually occurs after:

    Answer: Chronic use of an agonist

    Explanation: Continuous stimulation of receptors by agonists often leads to a decrease in receptor number or sensitivity (desensitization).

  46. Q46. Up-regulation or super-sensitivity is often a result of:

    Answer: Chronic exposure to an antagonist

    Explanation: Chronic blockade of receptors leads the cell to increase receptor density to maintain signaling.

  47. Q47. What is the primary characteristic of an Intracellular Receptor?

    Answer: It must be activated by lipid-soluble ligands

    Explanation: To reach intracellular receptors (cytoplasmic or nuclear), ligands must be lipid-soluble to cross the plasma membrane.

  48. Q48. In pharmacology, 'intrinsic activity' is a measure of:

    Answer: The drug's ability to activate the receptor and produce a response

    Explanation: Intrinsic activity (efficacy) is the property that distinguishes agonists from antagonists.

  49. Q49. The study of how drugs move through the body (absorption, distribution, metabolism, excretion) is:

    Answer: Pharmacokinetics

    Explanation: Pharmacokinetics (PK) describes the movement of the drug through the body.

  50. Q50. Which of the following is most likely to cause a 'Cholinergic Crisis'?

    Answer: Organophosphate insecticides

    Explanation: Organophosphates inhibit acetylcholinesterase, leading to a massive buildup of acetylcholine.

  51. Q51. The primary neurotransmitter of the parasympathetic nervous system is:

    Answer: Acetylcholine

    Explanation: Acetylcholine (ACh) is the neurotransmitter for all preganglionic fibers and postganglionic parasympathetic fibers.

  52. Q52. Which receptor subtype is found in the heart and increases heart rate when stimulated?

    Answer: Beta-1

    Explanation: Beta-1 adrenergic receptors are primarily located in the heart and increase rate and contractility.

  53. Q53. Which receptor subtype is primarily responsible for bronchodilation?

    Answer: Beta-2

    Explanation: Beta-2 adrenergic receptors are located in bronchial smooth muscle and cause relaxation (dilation) when stimulated.

  54. Q54. Atropine is classified as a(n):

    Answer: Muscarinic antagonist

    Explanation: Atropine is a competitive muscarinic receptor antagonist.

  55. Q55. Which of the following is an effect of alpha-1 receptor activation?

    Answer: Vasoconstriction

    Explanation: Alpha-1 receptors are found on vascular smooth muscle and cause contraction (vasoconstriction) when activated.

  56. Q56. A drug that mimics the effect of the sympathetic nervous system is called a(n):

    Answer: Sympathomimetic

    Explanation: Sympathomimetics 'mimic' the sympathetic nervous system.

  57. Q57. Salivation, Lacrimation, Urination, Defecation (SLUD) are signs of:

    Answer: Cholinergic stimulation

    Explanation: SLUD highlights the increased secretory and excretory functions associated with parasympathetic (cholinergic) activity.

  58. Q58. Pilocarpine is used clinically to treat glaucoma because it:

    Answer: Causes miosis and improves aqueous humor outflow

    Explanation: Pilocarpine is a muscarinic agonist that constricts the pupil (miosis), opening the trabecular meshwork.

  59. Q59. Which enzyme is responsible for the termination of acetylcholine action in the synapse?

    Answer: Acetylcholinesterase (AChE)

    Explanation: AChE hydrolyzes acetylcholine into acetate and choline rapidly in the synaptic cleft.

  60. Q60. Which of these is a non-selective beta-blocker?

    Answer: Propranolol

    Explanation: Propranolol blocks both Beta-1 and Beta-2 receptors, making it non-selective.

View on OmpathStudy